| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CHPF | 1.89e-15 | 35 | 106 | 10 | GO:0015020 |
| GeneOntologyMolecularFunction | retinoic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.50e-14 | 28 | 106 | 9 | GO:0001972 |
| GeneOntologyMolecularFunction | retinoid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.34e-12 | 48 | 106 | 9 | GO:0005501 |
| GeneOntologyMolecularFunction | isoprenoid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.08e-12 | 49 | 106 | 9 | GO:0019840 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PPARD PPARG UGT1A4 UGT1A1 UGT1A3 | 1.13e-11 | 107 | 106 | 11 | GO:0033293 |
| GeneOntologyMolecularFunction | carboxylic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRIN2A PPARD PPARG UGT1A4 UGT1A1 UGT1A3 | 5.35e-09 | 239 | 106 | 12 | GO:0031406 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CHPF | 8.81e-09 | 153 | 106 | 10 | GO:0008194 |
| GeneOntologyMolecularFunction | organic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRIN2A PPARD PPARG UGT1A4 UGT1A1 UGT1A3 | 1.06e-08 | 254 | 106 | 12 | GO:0043177 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CHPF | 1.85e-07 | 211 | 106 | 10 | GO:0016758 |
| GeneOntologyMolecularFunction | fatty acid binding | 1.77e-06 | 69 | 106 | 6 | GO:0005504 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CHPF | 3.14e-06 | 288 | 106 | 10 | GO:0016757 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 TAF1 | 5.14e-05 | 398 | 106 | 10 | GO:0046982 |
| GeneOntologyMolecularFunction | lipid binding | BPIFC UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PPARD PPARG TRIP10 C2CD5 UGT1A4 UGT1A1 UGT1A3 PASK SMO | 6.38e-05 | 988 | 106 | 16 | GO:0008289 |
| GeneOntologyMolecularFunction | steroid binding | 7.71e-05 | 133 | 106 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.19e-04 | 207 | 106 | 7 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.38e-04 | 212 | 106 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | peptidase activity | USP36 RELN ADAM19 PRSS38 HTRA3 OVCH1 USP20 TMPRSS3 CELA1 USP35 TMPRSS7 USP33 | 1.83e-04 | 654 | 106 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | protein kinase C binding | 4.20e-04 | 66 | 106 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.76e-04 | 430 | 106 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 5.32e-04 | 190 | 106 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 1.49e-03 | 11 | 106 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 1.78e-03 | 12 | 106 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 2.11e-03 | 431 | 106 | 8 | GO:0004984 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 2.23e-03 | 435 | 106 | 8 | GO:0004857 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.94e-16 | 21 | 106 | 9 | GO:0052695 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.14e-15 | 26 | 106 | 9 | GO:0019585 |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.14e-15 | 26 | 106 | 9 | GO:0006063 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 3.26e-12 | 5 | 106 | 5 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.95e-11 | 6 | 106 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.66e-11 | 13 | 106 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.51e-09 | 12 | 106 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.28e-09 | 5 | 106 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 8.57e-09 | 52 | 106 | 7 | GO:0008210 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 9.81e-09 | 6 | 106 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 9.81e-09 | 6 | 106 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.35e-07 | 10 | 106 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.35e-07 | 10 | 106 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | ZBTB20 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PFKL PPARD PPARG CPT1B NR1D1 UGT1A4 UGT1A1 UGT1A3 AGXT2 ADIPOR2 | 1.87e-07 | 731 | 106 | 17 | GO:0032787 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 6.70e-07 | 141 | 106 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.86e-06 | 40 | 106 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.69e-06 | 21 | 106 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A9 PPARD CUBN NR1D1 UGT1A4 UGT1A1 UGT1A3 BMPR1B | 3.78e-06 | 376 | 106 | 11 | GO:0008202 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CLSTN3 ZBTB20 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PFKL PPARD PPARG CPT1B NR1D1 UGT1A4 UGT1A1 UGT1A3 AGXT2 ADIPOR2 | 5.15e-06 | 1035 | 106 | 18 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CLSTN3 ZBTB20 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PFKL PPARD PPARG CPT1B NR1D1 UGT1A4 UGT1A1 UGT1A3 AGXT2 ADIPOR2 | 6.97e-06 | 1058 | 106 | 18 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CLSTN3 ZBTB20 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PFKL PPARD PPARG CPT1B NR1D1 UGT1A4 UGT1A1 UGT1A3 AGXT2 ADIPOR2 | 7.53e-06 | 1064 | 106 | 18 | GO:0006082 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 9.02e-06 | 94 | 106 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | RELN UGT1A10 UGT1A8 UGT1A7 UGT1A9 PFKL PPARD PPARG NR1D1 UGT1A1 UGT1A3 PASK BMPR1B ZBED6 | 1.08e-05 | 684 | 106 | 14 | GO:0010817 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.94e-05 | 222 | 106 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 2.62e-05 | 2 | 106 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.71e-05 | 34 | 106 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 4.61e-05 | 14 | 106 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | UGT1A10 UGT1A8 UGT1A7 UGT1A6 AOX1 UGT1A9 GRIN2A LYST UGT1A1 UGT1A3 LOX | 8.22e-05 | 525 | 106 | 11 | GO:0009410 |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 9.61e-05 | 89 | 106 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.15e-04 | 286 | 106 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.24e-04 | 94 | 106 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5T1 OR5T3 DMXL2 OR10H5 OR10J6P OR10T2 TTC8 OR10H1 OR2Z1 OR52K2 | 1.42e-04 | 465 | 106 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | pancreas morphogenesis | 1.56e-04 | 4 | 106 | 2 | GO:0061113 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.09e-04 | 105 | 106 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 2.11e-04 | 165 | 106 | 6 | GO:0045834 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid storage | 3.15e-04 | 26 | 106 | 3 | GO:0010888 | |
| GeneOntologyBiologicalProcess | positive regulation of ossification | 3.72e-04 | 66 | 106 | 4 | GO:0045778 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.94e-04 | 67 | 106 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5T1 OR5T3 DMXL2 OR10H5 OR10J6P OR10T2 TTC8 OR10H1 OR2Z1 OR52K2 | 5.17e-04 | 547 | 106 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | liver development | 6.20e-04 | 202 | 106 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 6.70e-04 | 205 | 106 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | negative regulation of microglial cell activation | 7.18e-04 | 8 | 106 | 2 | GO:1903979 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 7.67e-04 | 291 | 106 | 7 | GO:0045444 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5T1 OR5T3 OR10H5 OR10J6P GRIN2A OR10T2 OR10H1 RGS9BP OR2Z1 OR52K2 | 8.33e-04 | 582 | 106 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 8.91e-04 | 144 | 106 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 9.20e-04 | 9 | 106 | 2 | GO:0070640 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | OR5T3 ATG9B CLSTN3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 SLC43A1 UGT1A9 GRIN2A UGT1A4 UGT1A1 UGT1A3 RINT1 TMEM106C TMPRSS3 TMEM38A | 8.32e-05 | 1293 | 106 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | OR5T3 ATG9B CLSTN3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 SLC43A1 UGT1A9 GRIN2A UGT1A4 UGT1A1 UGT1A3 RINT1 TMEM106C TMPRSS3 TMEM38A | 8.83e-05 | 1299 | 106 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | OR5T3 ATG9B CLSTN3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 SLC43A1 UGT1A9 GRIN2A UGT1A4 UGT1A1 UGT1A3 RINT1 TMEM106C TMPRSS3 TMEM38A | 1.16e-04 | 1327 | 106 | 18 | GO:0042175 |
| MousePheno | abnormal hippocampus CA1 region morphology | 9.05e-06 | 28 | 67 | 4 | MP:0008263 | |
| MousePheno | increased insulin sensitivity | 3.13e-05 | 188 | 67 | 7 | MP:0002891 | |
| MousePheno | abnormal adipocyte glucose uptake | 4.70e-05 | 42 | 67 | 4 | MP:0004185 | |
| MousePheno | decreased energy dissipated prior to femur fracture | 6.77e-05 | 3 | 67 | 2 | MP:0013646 | |
| MousePheno | abnormal hippocampus region morphology | 1.02e-04 | 51 | 67 | 4 | MP:0008262 | |
| MousePheno | abnormal retina layer morphology | RELN TRIB2 ABCB5 NR1D1 LYST TTC8 ZNF836 BMPR1B GUCY1A1 ZNF616 | 1.33e-04 | 504 | 67 | 10 | MP:0003727 |
| MousePheno | abnormal brown fat cell morphology | 1.37e-04 | 55 | 67 | 4 | MP:0009116 | |
| MousePheno | abnormal Ammon gyrus morphology | 1.37e-04 | 55 | 67 | 4 | MP:0000815 | |
| MousePheno | increased adipocyte glucose uptake | 1.98e-04 | 24 | 67 | 3 | MP:0030016 | |
| MousePheno | abnormal retina neuronal layer morphology | 2.41e-04 | 441 | 67 | 9 | MP:0006069 | |
| Domain | UDPGT | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.18e-16 | 21 | 103 | 9 | PF00201 |
| Domain | UDPGT | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.18e-16 | 21 | 103 | 9 | PS00375 |
| Domain | UDP_glucos_trans | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.18e-16 | 21 | 103 | 9 | IPR002213 |
| Domain | Trypsin | 5.59e-05 | 121 | 103 | 6 | PF00089 | |
| Domain | Trypsin_dom | 5.59e-05 | 121 | 103 | 6 | IPR001254 | |
| Domain | Peptidase_S1_PA | 6.13e-05 | 123 | 103 | 6 | IPR009003 | |
| Domain | 1Cnucl_rcpt | 9.00e-05 | 3 | 103 | 2 | IPR003074 | |
| Domain | TRYPSIN_SER | 1.40e-04 | 90 | 103 | 5 | IPR033116 | |
| Domain | CUB | 1.53e-04 | 49 | 103 | 4 | PF00431 | |
| Domain | CUB | 1.65e-04 | 50 | 103 | 4 | SM00042 | |
| Domain | - | 1.93e-04 | 52 | 103 | 4 | 2.60.120.290 | |
| Domain | CUB | 2.08e-04 | 53 | 103 | 4 | PS01180 | |
| Domain | TRYPSIN_HIS | 2.64e-04 | 103 | 103 | 5 | IPR018114 | |
| Domain | CUB_dom | 2.75e-04 | 57 | 103 | 4 | IPR000859 | |
| Domain | TRYPSIN_SER | 3.02e-04 | 106 | 103 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 3.15e-04 | 107 | 103 | 5 | PS00134 | |
| Domain | Peptidase_S1A | 4.05e-04 | 113 | 103 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 4.39e-04 | 115 | 103 | 5 | PS50240 | |
| Domain | DUSP | 4.45e-04 | 6 | 103 | 2 | SM00695 | |
| Domain | DUSP | 4.45e-04 | 6 | 103 | 2 | PF06337 | |
| Domain | Tryp_SPc | 4.75e-04 | 117 | 103 | 5 | SM00020 | |
| Domain | USP_CS | 4.84e-04 | 66 | 103 | 4 | IPR018200 | |
| Domain | USP_1 | 6.05e-04 | 70 | 103 | 4 | PS00972 | |
| Domain | - | 6.21e-04 | 7 | 103 | 2 | 3.30.2230.10 | |
| Domain | DUSP | 6.21e-04 | 7 | 103 | 2 | PS51283 | |
| Domain | Pept_C19_DUSP | 6.21e-04 | 7 | 103 | 2 | IPR006615 | |
| Domain | UCH | 6.38e-04 | 71 | 103 | 4 | PF00443 | |
| Domain | USP_2 | 6.38e-04 | 71 | 103 | 4 | PS00973 | |
| Domain | USP_3 | 6.73e-04 | 72 | 103 | 4 | PS50235 | |
| Domain | USP_dom | 6.73e-04 | 72 | 103 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 6.73e-04 | 72 | 103 | 4 | IPR001394 | |
| Domain | ZnF_UBP | 1.60e-03 | 11 | 103 | 2 | SM00290 | |
| Domain | zf-C4 | 2.08e-03 | 46 | 103 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 2.08e-03 | 46 | 103 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.08e-03 | 46 | 103 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.08e-03 | 46 | 103 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.08e-03 | 46 | 103 | 3 | PS00031 | |
| Domain | ZnF_C4 | 2.08e-03 | 46 | 103 | 3 | SM00399 | |
| Domain | - | 2.21e-03 | 47 | 103 | 3 | 1.10.565.10 | |
| Domain | HOLI | 2.35e-03 | 48 | 103 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.35e-03 | 48 | 103 | 3 | IPR000536 | |
| Domain | Hormone_recep | 2.35e-03 | 48 | 103 | 3 | PF00104 | |
| Domain | Znf_UBP | 2.62e-03 | 14 | 103 | 2 | IPR001607 | |
| Domain | zf-UBP | 2.62e-03 | 14 | 103 | 2 | PF02148 | |
| Domain | ZF_UBP | 2.62e-03 | 14 | 103 | 2 | PS50271 | |
| Domain | - | 3.84e-03 | 57 | 103 | 3 | 3.30.50.10 | |
| Domain | WD40_repeat | 3.97e-03 | 272 | 103 | 6 | IPR001680 | |
| Domain | Znf_NHR/GATA | 4.03e-03 | 58 | 103 | 3 | IPR013088 | |
| Domain | Gal_Oxase/kelch_b-propeller | 4.23e-03 | 59 | 103 | 3 | IPR011043 | |
| Domain | Nucleotide_cyclase | 4.35e-03 | 18 | 103 | 2 | IPR029787 | |
| Domain | - | 4.35e-03 | 18 | 103 | 2 | 3.30.70.1230 | |
| Domain | WD_REPEATS_1 | 4.42e-03 | 278 | 103 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.50e-03 | 279 | 103 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.50e-03 | 279 | 103 | 6 | PS50294 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.84e-03 | 19 | 103 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 4.84e-03 | 19 | 103 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.84e-03 | 19 | 103 | 2 | PS50125 | |
| Domain | A/G_cyclase | 4.84e-03 | 19 | 103 | 2 | IPR001054 | |
| Domain | CYCc | 4.84e-03 | 19 | 103 | 2 | SM00044 | |
| Pathway | REACTOME_GLUCURONIDATION | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.70e-15 | 25 | 72 | 9 | M17787 |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.70e-15 | 25 | 72 | 9 | M605 |
| Pathway | WP_GLUCURONIDATION | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.11e-15 | 26 | 72 | 9 | M39404 |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.01e-15 | 28 | 72 | 9 | M19580 |
| Pathway | REACTOME_GLUCURONIDATION | 2.14e-13 | 24 | 72 | 8 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 3.13e-13 | 25 | 72 | 8 | MM15820 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.34e-13 | 41 | 72 | 9 | M7399 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.63e-12 | 72 | 72 | 10 | M9257 |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.62e-12 | 51 | 72 | 9 | M17726 |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.36e-12 | 52 | 72 | 9 | M14171 |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.44e-12 | 55 | 72 | 9 | M14933 |
| Pathway | WP_ESTROGEN_METABOLISM | 1.08e-11 | 22 | 72 | 7 | MM15888 | |
| Pathway | KEGG_RETINOL_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.11e-11 | 64 | 72 | 9 | M9488 |
| Pathway | REACTOME_ASPIRIN_ADME | 4.75e-11 | 44 | 72 | 8 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.75e-11 | 45 | 72 | 8 | MM15694 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.16e-11 | 70 | 72 | 9 | M16794 |
| Pathway | REACTOME_DRUG_ADME | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.01e-09 | 109 | 72 | 9 | M45012 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.01e-09 | 109 | 72 | 9 | M18788 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 5.83e-09 | 14 | 72 | 5 | M39328 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A9 ANKMY1 UGT1A4 UGT1A1 PASK | 4.93e-08 | 145 | 72 | 9 | M45512 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.77e-08 | 107 | 72 | 8 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 1.55e-07 | 119 | 72 | 8 | MM15692 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.07e-06 | 153 | 72 | 8 | MM15844 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.52e-06 | 39 | 72 | 5 | MM15695 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.69e-06 | 220 | 72 | 9 | M10320 |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 1.81e-06 | 18 | 72 | 4 | M39424 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 2.53e-06 | 6 | 72 | 3 | M39600 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.85e-06 | 20 | 72 | 4 | MM14721 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 3.15e-06 | 45 | 72 | 5 | M39615 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 4.08e-06 | 183 | 72 | 8 | M39588 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.35e-05 | 29 | 72 | 4 | M45015 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.52e-05 | 219 | 72 | 8 | MM14838 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.77e-05 | 31 | 72 | 4 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.02e-05 | 32 | 72 | 4 | M39567 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.02e-05 | 32 | 72 | 4 | MM14719 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.72e-05 | 12 | 72 | 3 | M39611 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 5.56e-05 | 15 | 72 | 3 | MM15697 | |
| Pathway | WP_NRF2_PATHWAY | 8.18e-05 | 141 | 72 | 6 | M39454 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.59e-04 | 21 | 72 | 3 | M39631 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.10e-04 | 23 | 72 | 3 | MM16639 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 3.81e-04 | 6 | 72 | 2 | M39437 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.09e-03 | 314 | 72 | 7 | M39428 | |
| Pathway | REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM | 1.93e-03 | 13 | 72 | 2 | MM15210 | |
| Pathway | WP_THERMOGENESIS | 2.25e-03 | 108 | 72 | 4 | M39746 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 2.25e-03 | 14 | 72 | 2 | M27098 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 2.25e-03 | 14 | 72 | 2 | MM14788 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.49e-03 | 53 | 72 | 3 | M8276 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.59e-03 | 15 | 72 | 2 | M27060 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.59e-03 | 15 | 72 | 2 | M47663 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 2.77e-03 | 55 | 72 | 3 | M39763 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.10e-03 | 118 | 72 | 4 | M39852 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 3.25e-03 | 381 | 72 | 7 | M48063 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.75e-23 | 9 | 107 | 9 | 22511988 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.75e-22 | 10 | 107 | 9 | 23642732 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.75e-22 | 10 | 107 | 9 | 11465080 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.75e-22 | 10 | 107 | 9 | 23371916 | |
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.75e-22 | 10 | 107 | 9 | 22558097 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.82e-21 | 12 | 107 | 9 | 19419973 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.82e-21 | 12 | 107 | 9 | 11434514 |
| Pubmed | 6.14e-21 | 8 | 107 | 8 | 20610558 | ||
| Pubmed | 6.14e-21 | 8 | 107 | 8 | 17179145 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.24e-20 | 13 | 107 | 9 | 22085899 |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.24e-20 | 13 | 107 | 9 | 25246029 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-20 | 14 | 107 | 9 | 21646302 | |
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-20 | 14 | 107 | 9 | 10836148 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-20 | 14 | 107 | 9 | 9295054 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-20 | 14 | 107 | 9 | 14672974 |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.97e-19 | 16 | 107 | 9 | 19414484 |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.17e-19 | 17 | 107 | 9 | 20639394 |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.58e-18 | 19 | 107 | 9 | 23281178 |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.14e-18 | 7 | 107 | 7 | 8467709 | |
| Pubmed | 2.14e-18 | 7 | 107 | 7 | 8464825 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 3.01e-18 | 12 | 107 | 8 | 20308471 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.20e-17 | 24 | 107 | 9 | 24625756 |
| Pubmed | 7.65e-17 | 9 | 107 | 7 | 1339448 | ||
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 PPARG UGT1A4 UGT1A1 UGT1A3 | 1.29e-16 | 66 | 107 | 11 | 19898482 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 7.36e-16 | 6 | 107 | 6 | 19204906 | |
| Pubmed | 2.05e-14 | 8 | 107 | 6 | 18052087 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.39e-13 | 57 | 107 | 9 | 21886157 |
| Pubmed | 2.51e-13 | 5 | 107 | 5 | 15057901 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 20297805 | ||
| Pubmed | 1.33e-11 | 18 | 107 | 6 | 20056724 | ||
| Pubmed | 1.39e-11 | 8 | 107 | 5 | 22579593 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.39e-11 | 8 | 107 | 5 | 12695355 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | AMPD3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 CUBN UGT1A4 UGT1A1 UGT1A3 | 5.88e-11 | 211 | 107 | 11 | 24097068 |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 8.47e-11 | 4 | 107 | 4 | 18223459 | |
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 1898728 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 15855726 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 9535849 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 9271343 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 8.47e-11 | 4 | 107 | 4 | 2108603 | |
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 8280139 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 1634050 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 8276413 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 17558305 | ||
| Pubmed | 1.14e-10 | 11 | 107 | 5 | 18695635 | ||
| Pubmed | 1.95e-10 | 12 | 107 | 5 | 18161889 | ||
| Pubmed | 1.26e-09 | 6 | 107 | 4 | 32527940 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 27514509 | ||
| Pubmed | 5.87e-09 | 8 | 107 | 4 | 15319294 | ||
| Pubmed | 6.17e-09 | 81 | 107 | 7 | 12838346 | ||
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.10e-09 | 190 | 107 | 9 | 24816252 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.05e-08 | 9 | 107 | 4 | 20732626 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 2.83e-08 | 3 | 107 | 3 | 20007669 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 12051676 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 17406868 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 19996319 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 12847094 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 2.83e-08 | 3 | 107 | 3 | 16969497 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 15247627 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 19364970 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 29519853 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 11179460 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 26247833 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 12732365 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 2.83e-08 | 3 | 107 | 3 | 24453052 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 20860988 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 19712005 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 23789755 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 19303655 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 24255116 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 26253087 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 20628391 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 2.82e-07 | 5 | 107 | 3 | 18597651 | |
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 26010150 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 16141797 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 20565459 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 7677729 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 19208777 | ||
| Pubmed | 1.09e-06 | 108 | 107 | 6 | 19956635 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 10748067 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 18719240 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 6.10e-06 | 12 | 107 | 3 | 19349540 | |
| Pubmed | 6.55e-06 | 147 | 107 | 6 | 29576527 | ||
| Pubmed | Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene. | 9.38e-06 | 2 | 107 | 2 | 24486511 | |
| Pubmed | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 9.38e-06 | 2 | 107 | 2 | 15864130 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 14677574 | ||
| Pubmed | Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population. | 9.38e-06 | 2 | 107 | 2 | 31132973 | |
| Pubmed | Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases. | 9.38e-06 | 2 | 107 | 2 | 24107399 | |
| Pubmed | The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis. | 9.38e-06 | 2 | 107 | 2 | 32198386 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 33075048 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 9621515 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8226884 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 10946897 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8068691 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18981166 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23545576 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20645257 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12821652 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21192919 | ||
| Pubmed | Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. | 9.38e-06 | 2 | 107 | 2 | 7715297 | |
| Interaction | UGT1A7 interactions | 8.84e-06 | 57 | 99 | 5 | int:UGT1A7 | |
| Cytoband | 2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-17 | 31 | 107 | 9 | 2q37 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 ANKMY1 UGT1A4 UGT1A1 UGT1A3 PASK | 6.60e-12 | 226 | 107 | 11 | chr2q37 |
| GeneFamily | UDP glucuronosyltransferases | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.37e-15 | 32 | 77 | 9 | 363 |
| GeneFamily | Ubiquitin specific peptidases | 9.44e-05 | 56 | 77 | 4 | 366 | |
| GeneFamily | Olfactory receptors, family 10 | 1.79e-04 | 66 | 77 | 4 | 157 | |
| GeneFamily | Nuclear hormone receptors | 1.19e-03 | 49 | 77 | 3 | 71 | |
| GeneFamily | Proteases, serine | 2.45e-03 | 63 | 77 | 3 | 738 | |
| Coexpression | NFE2L2.V2 | MACC1 PRSS38 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 UNKL | 4.06e-07 | 469 | 105 | 12 | M2870 |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.43e-06 | 177 | 107 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.43e-06 | 177 | 107 | 6 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 6.07e-06 | 187 | 107 | 6 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| Drug | AC1MRQNQ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.93e-22 | 9 | 107 | 9 | CID003522271 |
| Drug | DHPASiU | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.93e-22 | 9 | 107 | 9 | CID000197602 |
| Drug | 3-iodophenol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.93e-22 | 9 | 107 | 9 | CID000012272 |
| Drug | AC1L4J7U | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.93e-22 | 9 | 107 | 9 | CID000186631 |
| Drug | Chebi:32663 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.93e-22 | 9 | 107 | 9 | CID005460873 |
| Drug | 4-nitrophenyl)imidazole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.33e-20 | 11 | 107 | 9 | CID000123155 |
| Drug | AC1O5XMV | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.33e-20 | 11 | 107 | 9 | CID006442661 |
| Drug | N-OH-DABZ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.72e-19 | 12 | 107 | 9 | CID000051366 |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.72e-19 | 12 | 107 | 9 | CID000088735 |
| Drug | 2,4,6-TCB | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.72e-19 | 12 | 107 | 9 | CID000037247 |
| Drug | nonanoyl-N-methylglucamide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.72e-19 | 12 | 107 | 9 | CID000160090 |
| Drug | 7,7,7-triphenylheptanoic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.72e-19 | 12 | 107 | 9 | CID000276709 |
| Drug | HCG 004 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 PPARD PPARG UGT1A4 UGT1A1 UGT1A3 ADIPOR2 | 2.42e-19 | 54 | 107 | 13 | CID000064928 |
| Drug | tritanol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.58e-19 | 13 | 107 | 9 | CID000006457 |
| Drug | 5-azido-UDP-glucuronic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.58e-19 | 13 | 107 | 9 | CID003081279 |
| Drug | cotinine-N-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.58e-19 | 13 | 107 | 9 | CID000000411 |
| Drug | Benzamidoxime hydrochloride | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.15e-18 | 21 | 107 | 10 | CID000069186 |
| Drug | propranolol glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.56e-18 | 14 | 107 | 9 | CID000119515 |
| Drug | PCB-61 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.56e-18 | 14 | 107 | 9 | CID000036401 |
| Drug | phenanthridine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.71e-18 | 23 | 107 | 10 | CID000009189 |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.88e-18 | 15 | 107 | 9 | CID000040469 |
| Drug | afloqualone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.88e-18 | 15 | 107 | 9 | CID000002040 |
| Drug | naphthyl sulphate | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.88e-18 | 15 | 107 | 9 | CID000114775 |
| Drug | coumarin-3-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.88e-18 | 15 | 107 | 9 | CID000010752 |
| Drug | sulforaphane nitrile | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.88e-18 | 15 | 107 | 9 | CID000543743 |
| Drug | muraglitazar | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PPARD PPARG UGT1A4 UGT1A1 UGT1A3 | 7.93e-18 | 36 | 107 | 11 | CID000206044 |
| Drug | quercetin-3,4'-diglucoside | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.82e-18 | 16 | 107 | 9 | CID005320835 |
| Drug | 1'-hydroxyestragole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.82e-18 | 16 | 107 | 9 | CID000040003 |
| Drug | bilirubin-phosphate | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.82e-18 | 16 | 107 | 9 | CID005497144 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.87e-17 | 17 | 107 | 9 | CID000003573 |
| Drug | 6-hydroxychrysene | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.87e-17 | 17 | 107 | 9 | CID000037766 |
| Drug | SureCN12722713 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID005488034 |
| Drug | ethyl-beta-D-6-glucosiduronic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID000152226 |
| Drug | Br 2 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID003060900 |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID000036614 |
| Drug | ApApG | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID003081975 |
| Drug | C1 11-32 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID000443077 |
| Drug | C11131 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.72e-17 | 18 | 107 | 9 | CID000443076 |
| Drug | trans-3'-hydroxycotinine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.35e-17 | 29 | 107 | 10 | CID000000414 |
| Drug | 9-OH-risperidone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.04e-17 | 19 | 107 | 9 | CID000475100 |
| Drug | 5alpha-spirostan-3beta-ol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.04e-17 | 19 | 107 | 9 | CID000091433 |
| Drug | almokalant | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.04e-17 | 19 | 107 | 9 | CID003033962 |
| Drug | AC1L9E0Q | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 ABCB5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.49e-17 | 30 | 107 | 10 | CID000443095 |
| Drug | tectochrysin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.28e-16 | 20 | 107 | 9 | CID005281954 |
| Drug | AC1L1OBF | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.28e-16 | 20 | 107 | 9 | CID000032736 |
| Drug | 4'-hydroxydiclofenac | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.28e-16 | 20 | 107 | 9 | CID000116545 |
| Drug | indole-2-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRIN2A UGT1A4 UGT1A1 UGT1A3 | 2.02e-16 | 32 | 107 | 10 | CID000072899 |
| Drug | estriol-16-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.22e-16 | 21 | 107 | 9 | CID000122281 |
| Drug | dulcin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.22e-16 | 21 | 107 | 9 | CID000009013 |
| Drug | amonafide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.75e-16 | 22 | 107 | 9 | CID000050515 |
| Drug | N-methylpiperazine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.75e-16 | 22 | 107 | 9 | CID000053167 |
| Drug | amidoxime | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.13e-16 | 23 | 107 | 9 | CID000465967 |
| Drug | estradiol-3-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.13e-16 | 23 | 107 | 9 | CID000066651 |
| Drug | AS-3201 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.78e-16 | 24 | 107 | 9 | CID000153948 |
| Drug | 5-MOP | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-15 | 25 | 107 | 9 | CID000002355 |
| Drug | AzMC | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-15 | 25 | 107 | 9 | CID000064986 |
| Drug | N-acetylbenzidine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-15 | 25 | 107 | 9 | CID000018787 |
| Drug | 5,6-benzoquinoline | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-15 | 25 | 107 | 9 | CID000006796 |
| Drug | N-phenylmaleimide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-15 | 25 | 107 | 9 | CID000013662 |
| Drug | diflunisal | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-15 | 27 | 107 | 9 | CID000003059 |
| Drug | DiMeIQx | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-15 | 27 | 107 | 9 | CID000104739 |
| Drug | L 654969 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 ABCB5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.44e-15 | 42 | 107 | 10 | CID000005218 |
| Drug | CARMINE | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.09e-15 | 28 | 107 | 9 | CID000014749 |
| Drug | erucin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.09e-15 | 28 | 107 | 9 | CID000078160 |
| Drug | N-hydroxy-4-aminobiphenyl | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.09e-15 | 28 | 107 | 9 | CID000081261 |
| Drug | H-Ni | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.09e-15 | 28 | 107 | 9 | CID000445665 |
| Drug | androsterone glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 AOX1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.76e-15 | 43 | 107 | 10 | CID000114833 |
| Drug | AC1L1JAL | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.35e-15 | 29 | 107 | 9 | CID000004954 |
| Drug | 7-hydroxycoumarin glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.35e-15 | 29 | 107 | 9 | CID000125641 |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.35e-15 | 29 | 107 | 9 | CID005375667 |
| Drug | iberin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.35e-15 | 29 | 107 | 9 | CID000010455 |
| Drug | tolcapone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-14 | 30 | 107 | 9 | CID004659569 |
| Drug | paricalcitol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-14 | 30 | 107 | 9 | CID005281104 |
| Drug | dihydroartemisinin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-14 | 30 | 107 | 9 | CID000107770 |
| Drug | PCB 156 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.47e-14 | 31 | 107 | 9 | CID000038019 |
| Drug | 4'-HPPH | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.47e-14 | 31 | 107 | 9 | CID000017732 |
| Drug | 4-ethylphenol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.47e-14 | 31 | 107 | 9 | CID000031242 |
| Drug | Muracein C | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.03e-14 | 32 | 107 | 9 | CID003086323 |
| Drug | NNAL | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.03e-14 | 32 | 107 | 9 | CID000104856 |
| Drug | EM-652 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 NR1D1 UGT1A4 UGT1A1 UGT1A3 | 2.41e-14 | 49 | 107 | 10 | CID000155435 |
| Drug | R(-)-Denopamine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-14 | 33 | 107 | 9 | CID000003818 |
| Drug | norbuprenorphine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-14 | 33 | 107 | 9 | CID000114976 |
| Drug | AC1Q6OQG | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-14 | 33 | 107 | 9 | CID000009686 |
| Drug | 6-methylsalicylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-14 | 33 | 107 | 9 | CID000011279 |
| Drug | BP-3,6-quinol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-14 | 33 | 107 | 9 | CID000119292 |
| Drug | geniposide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.78e-14 | 33 | 107 | 9 | CID000107848 |
| Drug | estragole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.77e-14 | 34 | 107 | 9 | CID000008815 |
| Drug | AC1NOWCJ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.06e-14 | 35 | 107 | 9 | CID005120112 |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.06e-14 | 35 | 107 | 9 | CID010436171 |
| Drug | estrone-3-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.06e-14 | 35 | 107 | 9 | CID000115255 |
| Drug | DEPC | AMPD3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.63e-14 | 53 | 107 | 10 | CID000015357 |
| Drug | glucoraphanin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.72e-14 | 36 | 107 | 9 | CID000656556 |
| Drug | AC1L9DGV | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.72e-14 | 36 | 107 | 9 | CID000417381 |
| Drug | anisole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.72e-14 | 36 | 107 | 9 | CID000007519 |
| Drug | bevirimat | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.72e-14 | 36 | 107 | 9 | CID000457928 |
| Drug | acotiamide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.84e-14 | 37 | 107 | 9 | CID005282338 |
| Drug | 6beta-hydroxytestosterone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.84e-14 | 37 | 107 | 9 | CID000065543 |
| Drug | N-Fg | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.84e-14 | 37 | 107 | 9 | CID000445227 |
| Drug | l-borneol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.84e-14 | 37 | 107 | 9 | CID000010049 |
| Drug | 4-methylumbelliferyl glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.15e-13 | 38 | 107 | 9 | CID000091553 |
| Disease | X-11442 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.89e-23 | 9 | 104 | 9 | EFO_0021236 |
| Disease | X-11441 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.89e-23 | 9 | 104 | 9 | EFO_0021235 |
| Disease | circulating cell free DNA measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.89e-23 | 9 | 104 | 9 | EFO_0004739 |
| Disease | bilirubin measurement, response to xenobiotic stimulus | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.89e-23 | 9 | 104 | 9 | EFO_0004570, GO_0009410 |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.87e-22 | 10 | 104 | 9 | EFO_0802185 |
| Disease | bilirubin measurement, response to tenofovir | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.87e-22 | 10 | 104 | 9 | EFO_0004570, EFO_0009279 |
| Disease | X-21796 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.22e-21 | 11 | 104 | 9 | EFO_0800825 |
| Disease | insomnia, bilirubin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.22e-21 | 11 | 104 | 9 | EFO_0004570, EFO_0004698 |
| Disease | histidine betaine (hercynine) measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.22e-21 | 11 | 104 | 9 | EFO_0800972 |
| Disease | aldosterone measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.22e-21 | 11 | 104 | 9 | EFO_0010219 |
| Disease | biliverdin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.28e-20 | 12 | 104 | 9 | EFO_0021033 |
| Disease | X-11793--oxidized bilirubin measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.81e-20 | 8 | 104 | 8 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.62e-19 | 9 | 104 | 8 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.62e-19 | 9 | 104 | 8 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.62e-19 | 9 | 104 | 8 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.62e-19 | 9 | 104 | 8 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.62e-19 | 9 | 104 | 8 | EFO_0020691 | |
| Disease | X-21448 measurement | 8.09e-19 | 10 | 104 | 8 | EFO_0800816 | |
| Disease | X-23974 measurement | 8.09e-19 | 10 | 104 | 8 | EFO_0800867 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.40e-18 | 17 | 104 | 9 | EFO_0004611, EFO_0007800 |
| Disease | p-cresol glucuronide measurement | 8.85e-18 | 12 | 104 | 8 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 2.29e-17 | 13 | 104 | 8 | EFO_0802007 | |
| Disease | xanthurenate measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.56e-16 | 29 | 104 | 9 | EFO_0010551 |
| Disease | angiopoietin-related protein 1 measurement | 7.69e-16 | 18 | 104 | 8 | EFO_0801382 | |
| Disease | response to dolutegravir | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.92e-16 | 30 | 104 | 9 | EFO_0600017 |
| Disease | pregnenetriol sulfate measurement | 1.79e-15 | 11 | 104 | 7 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.79e-15 | 11 | 104 | 7 | EFO_0600039 | |
| Disease | tissue factor measurement | 3.55e-15 | 21 | 104 | 8 | EFO_0010623 | |
| Disease | pregnenetriol disulfate measurement | 9.28e-15 | 13 | 104 | 7 | EFO_0800587 | |
| Disease | serum N-desmethylclozapine measurement | 4.61e-14 | 8 | 104 | 6 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 4.61e-14 | 8 | 104 | 6 | EFO_0600038 | |
| Disease | X-21441 measurement | 1.04e-13 | 17 | 104 | 7 | EFO_0800814 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.94e-13 | 5 | 104 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.94e-13 | 5 | 104 | 5 | EFO_0801853 | |
| Disease | urate measurement, spine bone mineral density | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.44e-13 | 58 | 104 | 9 | EFO_0004531, EFO_0007701 |
| Disease | X-21339 measurement | 1.03e-11 | 7 | 104 | 5 | EFO_0800808 | |
| Disease | cholelithiasis | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.67e-11 | 88 | 104 | 9 | EFO_0004799 |
| Disease | gallstones | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.73e-10 | 108 | 104 | 9 | EFO_0004210 |
| Disease | thyroxine measurement | 5.74e-10 | 83 | 104 | 8 | EFO_0005130 | |
| Disease | hormone measurement | 6.33e-10 | 84 | 104 | 8 | EFO_0004730 | |
| Disease | 5-hydroxyindole sulfate measurement | 7.26e-10 | 5 | 104 | 4 | EFO_0800085 | |
| Disease | vitamin D deficiency | 3.52e-09 | 37 | 104 | 6 | EFO_0003762 | |
| Disease | vitamin D measurement, COVID-19 | 2.05e-08 | 49 | 104 | 6 | EFO_0004631, MONDO_0100096 | |
| Disease | blood 4-oxo-retinoic acid measurement | 4.25e-08 | 3 | 104 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 4.25e-08 | 3 | 104 | 3 | EFO_0800043 | |
| Disease | neuroblastoma, cutaneous melanoma | 4.55e-08 | 28 | 104 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | bilirubin measurement | ZBTB20 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PPARG UGT1A4 UGT1A1 UGT1A3 | 4.81e-07 | 442 | 104 | 11 | EFO_0004570 |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 8.44e-07 | 6 | 104 | 3 | EFO_0800566 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 9.36e-07 | 147 | 104 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | metabolite measurement | ZBTB20 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 AGXT2 | 4.74e-06 | 560 | 104 | 11 | EFO_0004725 |
| Disease | indoleacetate measurement | 5.01e-06 | 10 | 104 | 3 | EFO_0021015 | |
| Disease | X-24588 measurement | 1.19e-05 | 13 | 104 | 3 | EFO_0800898 | |
| Disease | non-high density lipoprotein cholesterol measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PPARG UGT1A4 UGT1A1 UGT1A3 FIZ1 | 4.42e-05 | 713 | 104 | 11 | EFO_0005689 |
| Disease | free androgen index | 5.53e-05 | 374 | 104 | 8 | EFO_0007005 | |
| Disease | vitamin D measurement | 1.93e-04 | 336 | 104 | 7 | EFO_0004631 | |
| Disease | arteriosclerosis (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PPARG UGT1A4 UGT1A3 | 5.71e-04 | 663 | 104 | 9 | EFO_0004615 |
| Disease | urinary bladder carcinoma | 6.16e-04 | 47 | 104 | 3 | MONDO_0004986 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 6.63e-04 | 11 | 104 | 2 | C1335302 | |
| Disease | dodecanedioate measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0021054 | |
| Disease | Metastatic melanoma | 9.26e-04 | 54 | 104 | 3 | C0278883 | |
| Disease | gliosarcoma | 1.43e-03 | 16 | 104 | 2 | C0206726 | |
| Disease | attention deficit hyperactivity disorder | 1.62e-03 | 354 | 104 | 6 | EFO_0003888 | |
| Disease | serum metabolite measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 AGXT2 | 1.87e-03 | 945 | 104 | 10 | EFO_0005653 |
| Disease | melanoma | 1.88e-03 | 248 | 104 | 5 | C0025202 | |
| Disease | Manic Disorder | 2.04e-03 | 71 | 104 | 3 | C0024713 | |
| Disease | HbA1c measurement, response to sulfonylurea | 2.47e-03 | 21 | 104 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | Manic | 2.67e-03 | 78 | 104 | 3 | C0338831 | |
| Disease | Hodgkin Disease | 2.71e-03 | 22 | 104 | 2 | C0019829 | |
| Disease | Depression, Bipolar | 2.77e-03 | 79 | 104 | 3 | C0005587 | |
| Disease | Mood Disorders | 3.00e-03 | 168 | 104 | 4 | C0525045 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITHAGSHGVYESICN | 371 | P35503 | |
| DFFSGIVTVSVGHCH | 106 | Q9BYV1 | |
| GVFCSGHNEAVSHYK | 551 | Q6ZSZ5 | |
| GFSHYSLTVHGCRIA | 406 | Q9BQT9 | |
| GFHATYEVLPSHTCG | 126 | Q7Z408 | |
| CGSLAYSVAFHVHRG | 181 | Q8N5R6 | |
| DHCFYHGTVRETELS | 111 | Q9H013 | |
| SVIHSSYCIGAAVPH | 331 | Q2M3G0 | |
| HCSVHYVSDSGDGVY | 186 | Q9NWN3 | |
| VVCFFAGHTHDGGYS | 271 | Q3LIE5 | |
| FTCHDHGATVLQYAP | 2896 | Q8TDJ6 | |
| VFCGIVGHTVRHEYT | 391 | Q96PN6 | |
| LHYTCKSGAHGIGDV | 111 | Q8N3C7 | |
| YSSVSGLCHLHTEIF | 306 | O00238 | |
| SFHCLYSGIGHGEDI | 181 | Q8N7S6 | |
| HCGEAGSITHLVSAF | 586 | Q01432 | |
| HLSGVKHATGEAIYC | 586 | Q06278 | |
| TTACYHHLVLTVGGS | 16 | Q6ZS82 | |
| VSSYLVHHGYCATAT | 261 | Q6VN20 | |
| FHTVYCHSEGVSRLF | 201 | Q86V24 | |
| TCASHLTVVVVHYGF | 241 | Q8NGA6 | |
| TSCDSLFAHLHGYVS | 251 | Q96RG2 | |
| GDIYVHADLHGATSC | 561 | O60524 | |
| KHVVHIACGSTYSAA | 551 | O95714 | |
| LHTIVRGFFHSACGS | 451 | O75387 | |
| CSSHITVVGLFYGAA | 241 | Q8NG97 | |
| ISHGHTVYVVHDGFE | 426 | P17858 | |
| YIHICNIYGEGDTHT | 241 | Q8TEB1 | |
| TGKCYHTFRGHTAEI | 166 | Q8N136 | |
| HCLVNGKYSVHGVTS | 211 | Q9UNI1 | |
| SVHYAGLHVCGGSIL | 76 | A1L453 | |
| SYHLFIVACAGAGAT | 221 | Q13491 | |
| LCGSHDGREVYAVTH | 2731 | P78509 | |
| CASHLTVVFVHYGCA | 241 | Q8NGX3 | |
| GDVASGFHYGVHACE | 136 | P20393 | |
| STCGAHLTGVTIYHG | 251 | Q8NG75 | |
| EHIGFHAKYSFTDCG | 2676 | O60494 | |
| SHAVCGTDGHTYANV | 86 | P83110 | |
| CYAQLSHAHVSFSGE | 161 | Q8NFQ6 | |
| LTGLGYFSCHSHTVV | 101 | Q9BQI4 | |
| HAYVSACQAAGGHVE | 1506 | Q9Y6R7 | |
| TVVQKADSGHYHCSG | 131 | Q7L513 | |
| SHHCYEGTVSFLPAQ | 321 | Q8TCT0 | |
| GRVASGVCFHLFTSH | 966 | Q6P158 | |
| AKGYTVLAAAATHCH | 291 | Q9P2S6 | |
| FHHFTVDVAGVGDIC | 656 | Q674R7 | |
| HLYGHTEEITSLFVC | 3611 | Q99698 | |
| HPSFTVVLTVCGHNY | 381 | Q6ZN28 | |
| ASHLEAHSGPATYGC | 346 | Q96SL8 | |
| RYTGHHAYASGCTIS | 401 | P28300 | |
| LKHCLYVVGGHTAAT | 386 | O14682 | |
| VVEGCTAYFLTHFHS | 721 | Q6PJP8 | |
| EYTCLAGNSIGFSHH | 336 | P22607 | |
| HEGYACTSIHGDRSQ | 461 | O15523 | |
| SHAKALGCHAVVGYS | 401 | Q86YS7 | |
| TDSFHLGYTETGHCL | 491 | Q92523 | |
| CGSHLTGVTIYHGTI | 271 | Q8NGG3 | |
| TCASHLTVVVVHYGF | 241 | Q9Y4A9 | |
| YRTEVAECHDHGSTF | 11 | Q9GZY0 | |
| AFHLTVVIVHYGCAS | 241 | Q8NGY7 | |
| GTCVSHIGAILAFYT | 241 | Q8NGK3 | |
| TQSSLETHHYVDCGG | 231 | Q9BVX2 | |
| DFNHSYHACGVIATI | 51 | O95807 | |
| VCGDKASGFHYGVHA | 76 | Q03181 | |
| HEGAVTHTFCGTIEY | 221 | Q9UBS0 | |
| ETVYCHTSPFLGSLH | 721 | P21675 | |
| TTFVCHGHLRVYEGF | 1031 | Q7RTY7 | |
| VCGDKASGFHYGVHA | 141 | P37231 | |
| YGSESHRGHLFVCVT | 421 | Q05823 | |
| FAVAHEATTCHGEIY | 446 | O94819 | |
| PIGHCVAIYHFEGSS | 541 | Q15642 | |
| CTGDHEGVHYSHLEL | 291 | Q8IZ52 | |
| HSVYVREGCASGHVV | 186 | P57727 | |
| CFSSFHSHEGVHTGE | 161 | Q6ZTB9 | |
| HTGTYHCVRFDGLSE | 121 | Q5JXA9 | |
| HVEAIACIGSNHFYS | 351 | Q8TAM2 | |
| ECGKVYSQYSHLVGH | 581 | Q08AN1 | |
| FITHAGSHGVYESIC | 366 | Q9HAW8 | |
| DGAHRVYDCGSHSLS | 681 | Q96PX8 | |
| ELHSVHGYPGTFASC | 411 | Q6NUQ1 | |
| VSLHFVGSAYCGASV | 621 | Q7RTY8 | |
| FYQIASAVAHCHDGG | 156 | Q92519 | |
| VVHSGVSSESGHYYC | 851 | Q9P2H5 | |
| TRAFITHAGSHGVYE | 366 | P22309 | |
| ITHAGSHGVYESICN | 371 | P35504 | |
| KGCFEHIGHAIDSYT | 216 | O00322 | |
| FITHAGSHGVYESIC | 366 | O60656 | |
| EEYSVPCAHAAHVTG | 1036 | Q9NNW5 | |
| HSYIAAFGAVTGLCT | 231 | Q99835 | |
| TYDLLSVICHHGTAG | 626 | Q9Y2K6 | |
| SVICHHGTAGSGHYI | 631 | Q9Y2K6 | |
| YKTGTCIHETDARGH | 116 | Q9H9P5 | |
| FYSGAVVSHHETALG | 261 | Q9HC78 | |
| HCYSVHHSLGRASGV | 661 | P86452 | |
| ISKCEEAFHVGISHY | 201 | Q9BWM5 | |
| VIGCGELSHYEFHTI | 321 | Q5TAH2 | |
| HAGSHGVYESICNGV | 371 | P19224 | |
| GCTVLHVVAAHSPGY | 241 | O15050 | |
| HSHSSPFDALEGYIC | 231 | Q9H6F2 | |
| VHAVSFYSKGHGVTS | 151 | A6NL46 | |
| YGNTVTLHCTREGHF | 181 | Q12836 | |
| GLYAVLVHSGYSCHA | 366 | Q9P275 | |
| FITHAGSHGVYESIC | 366 | Q9HAW7 | |
| YVGCGESQVDHSTIH | 81 | Q8TEY7 | |
| SVICHHGTASSGHYI | 661 | Q8TEY7 | |
| HCGRTFSHITGLTYH | 726 | Q6ZNA1 | |
| FITHAGSHGVYESIC | 366 | Q9HAW9 | |
| ITHAGSHGVYESICN | 371 | P22310 | |
| AYCVAGGLHKESDTH | 531 | Q02108 | |
| FSISRGIYSCIHGVH | 861 | Q12879 |